PTK2B Antikörper (AA 707-875)
Kurzübersicht für PTK2B Antikörper (AA 707-875) (ABIN7625773)
Target
Alle PTK2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 707-875
-
Verwendungszweck
- PTK2B Polyclonal Antibody
-
Produktmerkmale
- The PTK2B Polyclonal Antibody (Species: Human) has been validated for the following applications: ELISA, IHC, IF.
-
Aufreinigung
- Protein G purified
-
Reinheit
- >95%
-
Immunogen
- Recombinant Human Protein-tyrosine kinase 2-beta protein
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.03 % Proclin 300, 50 % glycerol, 0.01M PBS, pH 7.4
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- PTK2B (PTK2B Protein tyrosine Kinase 2 beta (PTK2B))
-
Andere Bezeichnung
- PTK2B
-
UniProt
- Q14289
-
Pathways
- EGFR Signaling Pathway, Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Cellular Glucan Metabolic Process, Cell-Cell Junction Organization, Regulation of Cell Size, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, Positive Regulation of fat Cell Differentiation, VEGF Signaling
Target
-